Patent · US Active

Preeclampsia biomarkers and related systems and methods

US11333672B2 · kind B2 · utility

0Cited by
101References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 19, 2021
Grant dateMay 17, 2022
Priority date
Expiry dateApr 19, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/60
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods, kits, tests, and systems for detecting, predicting, monitoring, or ruling out preeclampsia in pregnant women. Also provided herein are novel diagnostic markers, methods of data analysis, assay formats, and kits employing such markers to improve one or more characteristics of a test for identifying or ruling out preeclampsia based on biomarkers from patient samples.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.